Molecular characteristics of extended-spectrum β-lactamase-producing escherichia coli in riyadh: Emergence of CTX-M-15-producing E. coli ST131

Annals of Clinical Microbiology and Antimicrobials

Volumn 13, Issue 1, 2014, Pages

  Al Agamy, Mohamed H ^a,b   Shibl, Atef M ^a,d,e   Hafez, Mohamed M ^a,c   Al Ahdal, Mohammad N ^d   Memish, Ziad A ^e,f   Khubnani, Harish ^g  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

^b Cairo University   (Egypt)

^c CAIRO UNIVERSITY   (Egypt)

^d KING FAISAL SPECIALIST HOSPITAL AND RESEARCH CENTER   (Saudi Arabia)

^e ALFAISAL UNIVERSITY   (Saudi Arabia)

^f MINISTRY OF HEALTH   (Saudi Arabia)

^g Prince Salman Hospital   (Saudi Arabia)

Author keywords

lactam resistance; Class A lactamases; PFGE; Saudi Arabia; ST131

Indexed keywords

EXTENDED SPECTRUM BETA LACTAMASE;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL STRAIN; BACTERIUM DETECTION; BACTERIUM ISOLATE; BACTERIUM ISOLATION; CONTROLLED STUDY; ESCHERICHIA COLI; GENETIC TRAIT; GENOTYPE; MOLECULAR EPIDEMIOLOGY; NONHUMAN; PHENOTYPE; PULSED FIELD GEL ELECTROPHORESIS; REAL TIME POLYMERASE CHAIN REACTION; SAUDI ARABIA; SPUTUM; TERTIARY CARE CENTER; URINE;

BETA-LACTAMASES; ELECTROPHORESIS, GEL, PULSED-FIELD; ESCHERICHIA COLI; ESCHERICHIA COLI INFECTIONS; HUMANS; MICROBIAL SENSITIVITY TESTS; MOLECULAR TYPING; PREVALENCE; REAL-TIME POLYMERASE CHAIN REACTION; SAUDI ARABIA; TERTIARY CARE CENTERS;

EID: 84892178521     PISSN: None     EISSN: 14760711     Source Type: Journal    
DOI: 10.1186/1476-0711-13-4     Document Type: Article

References (34)

1. Pitout JD, Laupland KB. Extended-spectrum β-lactamase-producing Enterobacteriaceae: an emerging public-health concern. Lancet Infect Dis 2008, 8(3):159-166. 10.1016/S1473-3099(08)70041-0, 18291338.
2. Cantón R, Coque TM. The CTX-M beta-lactamase pandemic. Curr Opin Microbiol 2006, 9:466-475. 10.1016/j.mib.2006.08.011, 16942899.
3. Peirano G, Pitout JDD. Molecular epidemiology of Escherichia coli producing CTX-M β-lactamases: the worldwide emergence of clone ST131 O25:H4. Int J Antimicrob Agents 2010, 35:316-321. 10.1016/j.ijantimicag.2009.11.003, 20060273.
4. Banerjee R, Johnson JR. Escherichia coli ST131: Variations on a theme of clonal expansion. Enferm Infecc Microbiol Clin 2013, 31(6):355-356. 10.1016/j.eimc.2013.01.004, 23473674.
5. Banerjee R, Johnston B, Lohse C, Porter SB, Clabots C, Johnson JR. Escherichia coli sequence type 131 is a dominant, antimicrobial-resistant clonal group associated with healthcare and elderly hosts. Infect Control Hosp Epidemiol 2013, 34(4):361-369. 10.1086/669865, 23466908.
6. Dhanji H, Doumith M, Clermont O, Denamur E, Hope R, Livermore DM, et al. Real-time PCR for detection of the O25b-ST131 clone of Escherichia coli and its CTX-M-15-like extended-spectrum beta-lactamases. Int J Antimicrob Agents 2010, 36(4):355-358. 10.1016/j.ijantimicag.2010.06.007, 20691573.
7. Rogers BA, Sidjabat HE, Paterson DL. Escherichia coli O25b-ST131: a pandemic, multiresistant, community-associated strain. J Antimicrob Chemother 2011, 66(1):1-14. 10.1093/jac/dkq415, 21081548.
8. Vimont S, Boyd A, Bleibtreu A, Bens M, Goujon J-M, Garry L, Clermont O, Denamur E, Arlet G, Vandewalle A. The CTX-M-15-producing Escherichia coli clone O25b: H4-ST131 has high intestine colonization and urinary tract infection abilities. PLoS One 2012, 7(9):e46547. 10.1371/journal.pone.0046547, 3460912, 23029548.
9. Al-Agamy MH, Shibl AM, Elkhizzi NA, Meunier D, Turton JF, Livermore DM. Persistence of Klebsiella pneumoniae clones with OXA-48 or NDM carbapenemases causing bacteraemias in a Riyadh hospital. Diagn Microbiol Infect Dis 2013, 76(2):214-216. 10.1016/j.diagmicrobio.2013.02.006, 23518186.
10. Al-Agamy MH, Shibl AM, Tawfik AF. Prevalence and molecular characterization of extended-spectrum β-lactamase-producing Klebsiella pneumoniae in Riyadh, Saudi Arabia. Ann Saudi Med 2009, 29(4):253-257. 10.4103/0256-4947.55306, 2841451, 19587523.
11. Ahmad S, Al-Juaid NF, Alenzi FQ, Mattar EH, Bakheet O-S. Prevalence, antibiotic susceptibility pattern and production of extended-spectrum beta-lactamases amongst clinical isolates of Klebsiella pneumoniae at armed forces hospital in Saudi Arabia. J Coll Phys Surg Pak 2009, 9(4):264-265.
12. Shibl AM, Al-Agamy MH, Khubnani H, Senok AC, Tawfik AF, Livermore DM. High prevalence of acquired quinolone-resistance genes among Enterobacteriaceae from Saudi Arabia with CTX-M-15 β-lactamase. Diagn Microbiol Infect Dis 2012, 73(4):350-353. 10.1016/j.diagmicrobio.2012.04.005, 22633335.
13. Tawfik AF, Alswailem AM, Shibl AM, Al-Agamy MH. Prevalence and genetic characteristics of TEM, SHV, and CTX-M in clinical Klebsiella pneumoniae isolates from Saudi Arabia. Micro Drug Resist 2011, 17(3):383-388.
14. Kader AA, Kumar A. Prevalence and antimicrobial susceptibility of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella pneumoniae in a general hospital. Ann Saudi Med 2005, 25(3):239-242.
15. Khanfar HS, Bindayna KM, Senok AC, Botta GA. Extended spectrum beta-lactamases (ESBL) in Escherichia coli and Klebsiella pneumoniae: trends in the hospital and community settings. J Infect Dev Ctries 2009, 3(4):295-299.
16. Al-Otaibi FE, Bukhari EE. Clinical and laboratory profiles of urinary tract infections caused by extended-spectrum beta-lactamase-producing Escherichia coli in a tertiary care center in central Saudi Arabia. Saudi Med J 2013, 34(2):171-176.
17. Bindayna K, Khanfar HS, Senok AC, Botta GA. Predominance of CTX-M genotype among extended spectrum beta lactamase isolates in a tertiary hospital in Saudi Arabia. Saudi Med J 2010, 31(8):859-863.
18. Clinical and Laboratory Standards Institute Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically, 7th ed. Approved standard M02-A11 2012, Wayne: CLSI, Clinical and Laboratory Standards Institute.
19. Dallenne C, Da Costa A, Decré D, Favier C, Arlet G. Development of a set of multiplex PCR assays for the detection of genes encoding important beta-lactamases in Enterobacteriaceae. J Antimicrob Chemother 2010, 65:490-495. 10.1093/jac/dkp498, 20071363.
20. Woodford N, Ward ME, Kaufmann ME, Turton J, Fagan EJ, James D, Johnson AP, Pike R, Warner M, Cheasty T, Pearson A, Harry S, Leach JB, Loughrey A, Lowes JA, Warren RE, Livermore DM. Community and hospital spread of Escherichia coli producing CTX-M extended-spectrum β-lactamases in the UK. J Antimicrob Chemother 2004, 54(4):735-743. 10.1093/jac/dkh424, 15347638.
21. Gautom RK. Rapid pulsed-field gel electrophoresis protocol for typing of Escherichia coli O157:H7 and other gram-negative organisms in 1 day. J Clin Microbiol 1997, 35(11):2977-2980. 230100, 9350772.
22. Tenover FC, Arbeit RD, Goering RV, Mickelsen PA, Murray BE, Persing DH, Swaminathan B. Interpreting chromosomal DNA restriction patterns produced by pulsed-field gel electrophoresis: criteria for bacterial strain typing. J Clin Microbiol 1995, 33(9):2233-2239. 228385, 7494007.
23. Bonnet R, Recule C, Baraduc R, Chanal C, Sirot D, De Champs C, Sirot J. Effect of D240G substitution in a novel ESBL CTX-M-27. J Antimicrob Chemother 2003, 52(1):29-35. 10.1093/jac/dkg256, 12775683.
24. Nicolas-Chanoine MH, Blanco J, Leflon-Guibout V, Demarty R, Alonso MP, Canica MM, Park YJ, Lavigne JP, Pitout J, Johnson JR. Intercontinental emergence of Escherichia coli clone O25:H4-ST131 producing CTX-M-15. J Antimicrob Chemother 2008, 61(2):273-281.
25. Lau SH, Reddy S, Cheesbrough J, Bolton FJ, Willshaw G, Cheasty T, Fox AJ, Upton M. Major uropathogenic Escherichia coli strain isolated in the northwest of England identified by multilocus sequence typing. J Clin Microbiol 2008, 46(3):1076-1080. 10.1128/JCM.02065-07, 2268376, 18199778.
26. Johnson JR, Johnston B, Clabots C, Kuskowski MA, Castanheira M. Escherichia coli sequence type ST131 as the major cause of serious multidrug-resistant E. coli infections in the United States. Clin Infect Dis 2010, 51(3):286-294. 10.1086/653932, 20572763.
27. Sidjabat HE, Paterson DL, Adams-Haduch JM, Ewan L, Pasculle AW, Muto CA, Tian GB, Doi Y. Molecular epidemiology of CTX-M-producing Escherichia coli isolates at a tertiary medical center in western Pennsylvania. Antimicrob Agents Chemother 2009, 53:4733-4739. 10.1128/AAC.00533-09, 2772316, 19687234.
28. Severin JA, Mertaniasih NM, Kuntaman K, Lestari ES, Purwanta M, Lemmens-Den Toom N, Duerink DO, Hadi U, van Belkum A, Verbrugh HA, Goessens WH, Study Group 'Antimicrobial Resistance in Indonesia: Prevalence and Prevention' (AMRIN) Molecular characterization of extended-spectrum beta-lactamases in clinical Escherichia coli and Klebsiella pneumoniae isolates from Surabaya, Indonesia. J Antimicrob Chemother 2010, 65(3):465-469. 10.1093/jac/dkp471, 20053690, Study Group 'Antimicrobial Resistance in Indonesia: Prevalence and Prevention' (AMRIN).
29. Markovska R, Schneider I, Ivanova D, Keuleyan E, Stoeva T, Sredkova M, Markova B, Bojkova K, Gergova R, Bauernfeind A, Mitov I. High prevalence of CTX-M-15-producing O25b-ST131 Escherichia coli clone in Bulgarian hospitals. Microb Drug Resist 2012, 18(4):390-395. 10.1089/mdr.2011.0186, 22352448.
30. Pitout JD, Gregson DB, Campbell L, Laupland KB. Molecular characteristics of extended-spectrum-β-lactamase-producing Escherichia coli isolates causing bacteremia in the Calgary health region from 2000 to 2007: emergence of clone ST131 as a cause of community-acquired infections. Antimicrob Agents Chemother 2009, 53(7):2846-2851. 10.1128/AAC.00247-09, 2704701, 19380595.
31. Smet A, Martel A, Persoons D, Dewulf J, Heyndrickx M, Claeys G, Lontie M, Van Meensel B, Herman L, Haesebrouck F, Butaye P. Characterization of extended-spectrum β-lactamases produced by Escherichia coli isolated from hospitalized and nonhospitalized patients: emergence of CTX-M-15-producing strains causing urinary tract infections. Microb Drug Resist 2010, 16(2):129-134. 10.1089/mdr.2009.0132, 20370505.
32. Peirano G, Costello M, Pitout JD. Molecular epidemiology over an 11-year period (2000 to 2010) of extended-spectrum β-lactamase- producing Escherichia coli causing bacteremia in a centralized Canadian region. Int J Antimicrob Agents 2010, 36(1):19-23. 10.1016/j.ijantimicag.2010.02.016, 20359869.
33. Croxall G, Hale J, Weston V, Manning G, Cheetham P, Achtman M, McNally A. Molecular epidemiology of extraintestinal pathogenic Escherichia coli isolates from a regional cohort of elderly patients highlights the prevalence of ST131 strains with increased antimicrobial resistance in both community and hospital care settings. J Antimicrob Chemother 2011, 66(11):2501-2508. 10.1093/jac/dkr349, 21862477.
34. Peirano G, van der Bij AK, Gregson DB, Pitout JD. Molecular epidemiology over an 11-year period (2000 to 2010) of extended-spectrum β-lactamase-producing Escherichia coli causing bacteremia in a centralized Canadian Region. J Clin Microbiol 2012, 50(2):294-299. 10.1128/JCM.06025-11, 3264152, 22162555.